Signal2026-06-18
ClinicalTrials.gov

[EARLY_PHASE1] CS-121 APOC3 Base Editing in Severe Hypertriglyceridemia

Part of

Emerging Biomolecular Targets In Therapy

Open primary sourceRead on Substack